What we do
Precision Medicines is a biotechnology company focussed on acquiring and developing novel cancer therapies alongside companion biomarkers that target specific cancer sub types.
The development programs are focussed on genomically defined cancer sub types using a precision or personalised medicine approach, whereby therapies are co-developed with companion biomarkers to target those patients most likely to benefit from them.
Growth through partnering
Precision Medicines partners with biotech, pharma, academic and clinical centres, taking responsibility for developing cancer therapies which have evidence of significant clinical benefit in patient subsets or niche areas.